0.00
100.00%
-3.875
Dopo l'orario di chiusura:
.15
0.15
+
Virios Therapeutics Inc Azioni (VIRI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
34.87%
0.0228
|
0.035 | 0.0392 | 0.0363 | 0.0404 |
Operating Expenses
|
15.46%
1.3141
|
1.1381 | 1.2743 | 1.4772 | 1.5573 |
Benefits Costs and Expenses |
15.46%
1.3141
|
1.1381 | 1.2743 | 1.4772 | 1.5573 |
Costs And Expenses |
15.46%
1.3141
|
1.1381 | 1.2743 | 1.4772 | 1.5573 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
15.46%
-1.3141
|
-1.1381 | -1.2743 | -1.4772 | -1.5573 |
Net Interest Income/Expense |
34.87%
0.0228
|
0.035 | 0.0392 | 0.0363 | 0.0404 |
Interest Income/Expense After Provision For Losses |
34.87%
0.0228
|
0.035 | 0.0392 | 0.0363 | 0.0404 |
Income/Loss From Continuing Operations Before Tax |
17.06%
-1.2913
|
-1.1032 | -1.2351 | -1.4409 | -1.5169 |
Income/Loss From Continuing Operations After Tax |
17.06%
-1.2913
|
-1.1032 | -1.2351 | -1.4409 | -1.5169 |
Net Income/Loss
|
17.06%
-1.2913
|
-1.1032 | -1.2351 | -1.4409 | -1.5169 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
11,777%
19.26
|
0.1621 | 19.09 | 18.41 | 18.33 |
Diluted Average Shares |
11,777%
19.26
|
0.1621 | 19.09 | 18.41 | 18.33 |
Basic Earnings Per Share |
40.00%
-0.07
|
-0.05 | -0.06 | -0.08 | -0.08 |
Diluted Earnings Per Share |
40.00%
-0.07
|
-0.05 | -0.06 | -0.08 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):